Gierse J K, Hauser S D, Creely D P, Koboldt C, Rangwala S H, Isakson P C, Seibert K
Searle Inflammatory Disease Research, Monsanto Company, St. Louis, MO 63167.
Biochem J. 1995 Jan 15;305 ( Pt 2)(Pt 2):479-84. doi: 10.1042/bj3050479.
The enzyme cyclo-oxygenase catalyses the oxygenation of arachidonic acid, leading to the formation of prostaglandins. Recently two forms of cyclo-oxygenase have been described: a constitutive (COX-1) enzyme present in most cells and tissues, and an inducible (COX-2) isoenzyme observed in many cells in response to pro-inflammatory cytokines. Constitutive and inducible forms of human cyclo-oxygenase (hCOX-1 and hCOX-2) were cloned and expressed in insect cells, utilizing a baculovirus expression system. hCOX-1 had a specific activity of 18.8 mumol of O2/mg with a Km of 13.8 microM for arachidonate and Vmax. of 1500 nmol of O2/nmol of enzyme, whereas hCOX-2 had a specific activity of 12.2 mumol of O2/mg with a Km of 8.7 microM for arachidonate and a Vmax. of 1090 nmol of O2/nmol of enzyme. Indomethacin inhibited both hCOX-1 and hCOX-2, whereas NS-398 and Dup-697 selectively inhibited hCOX-2. Both NS-398 and Dup-697 exhibited time-dependent inactivation of hCOX-2, as did indomethacin on both enzymes. The competitive inhibitor of hCOX-1, mefenamic acid, also displayed competitive inhibition of hCOX-2. These results demonstrate the ability to generate selective non-steroidal anti-inflammatory drugs (NSAIDs), which could provide useful improvement therapeutically in the treatment of chronic inflammatory disease.
环氧化酶催化花生四烯酸的加氧反应,生成前列腺素。最近已描述了两种形式的环氧化酶:一种是存在于大多数细胞和组织中的组成型(COX-1)酶,另一种是在许多细胞中响应促炎细胞因子而观察到的诱导型(COX-2)同工酶。利用杆状病毒表达系统,克隆了人环氧化酶(hCOX-1和hCOX-2)的组成型和诱导型形式,并在昆虫细胞中进行表达。hCOX-1的比活性为18.8 μmol O2/mg,对花生四烯酸的Km为13.8 μM,Vmax为1500 nmol O2/nmol酶,而hCOX-2的比活性为12.2 μmol O2/mg,对花生四烯酸的Km为8.7 μM,Vmax为1090 nmol O2/nmol酶。吲哚美辛对hCOX-1和hCOX-2均有抑制作用,而NS-398和Dup-697选择性抑制hCOX-2。NS-398和Dup-697均表现出对hCOX-2的时间依赖性失活,吲哚美辛对两种酶也有此作用。hCOX-1的竞争性抑制剂甲芬那酸对hCOX-2也表现出竞争性抑制作用。这些结果证明了生成选择性非甾体抗炎药(NSAIDs)的能力,这在慢性炎症性疾病的治疗中可能会带来有益的治疗改善。